Literature DB >> 28181999

Breakthrough in the prevention of mother-to-child hepatitis B transmission?

E P Masoumy1, B K Stansfield2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28181999     DOI： 10.1038/jp.2016.269

Source DB:  PubMed          Journal:  J Perinatol        ISSN： 0743-8346            Impact factor:   2.521


× No keyword cloud information.
  9 in total

1.  Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy.

Authors:  Chloe L Thio; Nan Guo; Chan Xie; Kenrad E Nelson; Stephan Ehrhardt
Journal:  Lancet Infect Dis       Date:  2015-07-02       Impact factor: 25.071

2.  Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2.

Authors:  Sihem Benaboud; Alain Pruvost; Patrick A Coffie; Didier K Ekouévi; Saïk Urien; Elise Arrivé; Stéphane Blanche; Frédéric Théodoro; Divine Avit; François Dabis; Jean-Marc Tréluyer; Déborah Hirt
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

3.  Antenatal lamivudine to reduce perinatal hepatitis B transmission: a cost-effectiveness analysis.

Authors:  Unzila A Nayeri; Erika F Werner; Christina S Han; Christian M Pettker; Edmund F Funai; Stephen F Thung
Journal:  Am J Obstet Gynecol       Date:  2012-06-11       Impact factor: 8.661

4.  Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.

Authors:  Calvin Q Pan; Zhongping Duan; Erhei Dai; Shuqin Zhang; Guorong Han; Yuming Wang; Huaihong Zhang; Huaibin Zou; Baoshen Zhu; Wenjing Zhao; Hongxiu Jiang
Journal:  N Engl J Med       Date:  2016-06-16       Impact factor: 91.245

5.  A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

Authors:  Susan T Goldstein; Fangjun Zhou; Stephen C Hadler; Beth P Bell; Eric E Mast; Harold S Margolis
Journal:  Int J Epidemiol       Date:  2005-10-25       Impact factor: 7.196

6.  Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers.

Authors:  H Zou; Y Chen; Z Duan; H Zhang; C Pan
Journal:  J Viral Hepat       Date:  2011-08-01       Impact factor: 3.728

7.  Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.

Authors:  W-M Xu; Y-T Cui; L Wang; H Yang; Z-Q Liang; X-M Li; S-L Zhang; F-Y Qiao; F Campbell; C-N Chang; S Gardner; M Atkins
Journal:  J Viral Hepat       Date:  2008-10-08       Impact factor: 3.728

Review 8.  Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis.

Authors:  Robert S Brown; Brian J McMahon; Anna S F Lok; John B Wong; Ahmed T Ahmed; Mohamed A Mouchli; Zhen Wang; Larry J Prokop; Mohammad Hassan Murad; Khaled Mohammed
Journal:  Hepatology       Date:  2015-11-13       Impact factor: 17.425

Review 9.  #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.

Authors:  Jodie Dionne-Odom; Alan T N Tita; Neil S Silverman
Journal:  Am J Obstet Gynecol       Date:  2015-10-08       Impact factor: 8.661
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.